Aspire Biopharma Holdings, Inc. (ASBP) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US7389203057
Aspire Biopharma Holdings, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 6,202.00 USD |
| Gross profit | -116.00 USD |
| Operating income | -19.35 m USD |
| EBIT | -15.95 m USD |
| Net income | -24.48 m USD |
| Diluted EPS – continuing operations | -16.38 USD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
More stocks
- Clean Energy Technologies, Inc. (CETY)
- Thunder Power Holdings, Inc. (AIEV)
- MINERALRITE Corp (RITE)
- Hepion Pharmaceuticals, Inc. (HEPA)
- Tempus AI, Inc. (TEM)
- Fabric.AI, Inc. (FABC)
- T Stamp Inc (IDAI)
- Pharma-Bio Serv, Inc. (PBSV)
- VIP Play, Inc. (VIPZ)
- Next Technology Holding Inc. (NXTT)
- Genvor Inc (GNVR)
- BION ENVIRONMENTAL TECHNOLOGIES INC (BNET)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.